RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1979; 41(01): 217-219
DOI: 10.1055/s-0039-1687656
DOI: 10.1055/s-0039-1687656
Dedication
Invited discussant
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
16. April 2019 (online)
-
Reference
- 1 Boissel J.P.. 1978; Prevention des accidents thrombo-emboliques systémiques chez les porteurs de prothèses valvulaires artificielles: essai coopératif contrôlé du dipyridamole, Coeur. 9: 915.
- 2 Canner P.L.. 1978; Monitoring clinical trial for evidence of adverse or beneficial treatment effects.. In Boissel J.P., Klimt C.R.. Multicenter Controlled Clinical Trials. Principles and problems, INSERM 76: 1979.
- 3 C.D.P. Research Group. 1975; Clofibrate and Niacin in Coronary Heart Disease.. Journal of American Medical Association 231: 360.
- 4 Meinert C.L.. 1978; Quality Assurance and Clinical Evaluation of Treatments. In Boissel J.P., Klimt C.R.. Multicenter Controlled Clinical Trials. Principles and problems, INSERM 76: 1979.
- 5 Oliver M.F.. 1971; Ischaemic heart disease: A secondary prevention trial using Clofibrate.. British Medical Journal 4: 775.